Yiu, Z. Z. N ;
Ashcroft, D. M ;
Evans, I...
Yiu , Z Z N , Ashcroft , D M , Evans , I , McElhone , K , Lunt , M , Smith , C H , Walton , S , Murphy , R , Reynolds , N J , Ormerod , A D , Griffiths , C E M , Warren , R B , Irshad , S , Wilde , V , Tahir , S , Ali , H , Mason , K , Hussain , S , Granger , E , Chalmers , R , Flohr , C , Watson , K , Prieto-Merino , D , Barker , J , Benham , M , Burden , D , Griffiths , C , Kirby , B , Lawson , L , Ormerod , A , Owen , C , Reynolds , N , Smith , C H & Warren , R 2019 , ' Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the UK and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR) ' , British Journal of Dermatology , vol. 180 , no. 2 , pp. 329-337 . https://doi.org/10.1111/bjd.17036.
,
2019
